Cas 135334-89-3,Acetic acid, [4-(5-cyano-1,6-dihydro-2-methyl-6-oxo-3-pyridinyl)phenoxy]-, ethyl ester

135334-89-3

Post Buying Request

Basic information

Product Name: Acetic acid, [4-(5-cyano-1,6-dihydro-2-methyl-6-oxo-3-pyridinyl)phenoxy]-, ethyl ester
Synonyms:
CAS NO:135334-89-3
Molecular Formula: C17H16N2O4
Molecular Weight: 312.325
EINECS: N/A
Product Categories: N/A
Mol File: 135334-89-3.mol

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Acetic acid, [4-(5-cyano-1,6-dihydro-2-methyl-6-oxo-3-pyridinyl)phenoxy]-, ethyl ester(CAS DataBase Reference)
NIST Chemistry Reference: Acetic acid, [4-(5-cyano-1,6-dihydro-2-methyl-6-oxo-3-pyridinyl)phenoxy]-, ethyl ester(135334-89-3)
EPA Substance Registry System: Acetic acid, [4-(5-cyano-1,6-dihydro-2-methyl-6-oxo-3-pyridinyl)phenoxy]-, ethyl ester(135334-89-3)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 135334-89-3(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

135334-89-3 Suppliers

Recommended suppliers

135334-89-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 135334-89-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,3,5,3,3 and 4 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 135334-89:
(8*1)+(7*3)+(6*5)+(5*3)+(4*3)+(3*4)+(2*8)+(1*9)=123
123 % 10 = 3
So 135334-89-3 is a valid CAS Registry Number.

135334-89-3Upstream product

135334-89-3Downstream Products

135334-75-7 5-(4-carboxymethoxyphenyl)-6-methyl-2-oxo-1,2-dihydro-3-pyridinecarbonitrile

135334-89-3Relevant academic research and scientific papers

COMPOUNDS WITH PHOSPHODIESTERASE INHIBITING AND CALCIUM CHANNEL BLOCKING ACTIVITIES

-

Page/Page column 33, (2010/02/11)

The present invention provides compounds that possess inhibitory activity against PDE-3 and L-type calcium channels. The present invention further provides pharmaceutical compositions comprising such compounds and methods of using such compounds for treating cardiovascular disease, stroke, epilepsy, ophthalmic disorder or migraine.

DIHYDROPYRIDINE COMPOUNDS HAVING SIMULTANEOUS ABILITY TO BLOCK L-TYPE CALCIUM CHANNELS AND TO INHIBIT PHOSPHODIESTERASE TYPE 3 ACTIVITY

-

Page 36; 38, (2010/02/06)

COMPOUNDS WITH MIXED PDE-INHIBITORY AND β-ADRENERGIC ANTAGONIST OR PARTIAL AGONIST ACTIVITY FOR TREATMENT OF HEART FAILURE

-

Page 50-51, (2010/02/07)

This invention provides compounds that possess inhibitory activity against β--adrenergic receptors and phosphodiesterase PDE, including phosphodiesterase 3 (PDE3 ). This invention further provides pharmaceutical compositions comprising such -compounds; methods of using such compounds for treating cardiovascular disease, stroke, epilepsy, ophthalmic disorder or migraine; and methods of preparing pharmaceutical compositions and compounds that possess inhibitory activity against ?-adrenergic receptors and PDE.

PYRIDONE NITRILES USEFUL IN TREATING CARDIOVASCULAR DISEASE

-

, (2008/06/13)

Pyridones of formula (I) for treating congestive heart failure: STR1 wherein: R 1 and R 2 are a variety of phenyl substituents, L is a divalent alkylene or amide containing alkylene linking group. Pharmaceutical composition, methods for their use in treat

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 135334-89-3